Seawolf launched with $100M for a non-viral gene therapy it hopes can tackle obesity, muscle loss and osteoporosis at once. endpoints.news/seawolf-launch…
Endpoints News
Verified account This account is verified. Learn more@endpts
The biopharma world is here. Get the industry’s most comprehensive daily news reports at endpts.com/subscribe
80 Following 33K Followers 51K Posts
Latest posts 5
Sofinnova closed its second crossover fund at €725M to fill the financing gap for late-stage European biotechs. endpoints.news/sofinnova-clos…
The FDA rejected Summit and Akeso's ivonescimab in a narrow lung cancer setting, sending both stocks down more than 20%. endpoints.news/fda-rejects-su…
Milestone is cutting 20% of its staff, with its CMO and CFO exiting, as heart drug Cardamyst brought in $1M in Q3 sales. endpoints.news/milestone-cuts…
Moderna says it's "on track and ready" to make thousands of doses of its cancer vaccine as it prepares to file with the FDA by year-end. endpoints.news/moderna-readie…